entertainment -WSS

entertainment

author：focus 2025-09-29 19:07:16 - browse：66831

The building exterior of AstraZeneca, a pharmaceutical and biopharmaceutical company, under cloudless blue sky — coverage from STAT — Adobe

WILMINGTON, Del. — Wednesday was the first time that a federal judge asked questions in-person of drug industry lawyers who are trying to stop Medicare from negotiating drug prices. It didn’t go well for them.

AstraZeneca’s lawyers argued that Medicare’s new powers amount to a taking of their property rights without due process. But Colm Connolly, chief judge of the U.S. District Court of Delaware, said he doesn’t understand how the law deprives AstraZeneca of its property. He asked Catherine Stetson, who represents AstraZeneca, multiple times to explain what property the company would lose due to Medicare price negotiation. Stetson said it’s both the patent and the drug that’s subject to the patent.

“You’re free to do what you want,” Connolly said, adding that drug companies don’t have to sell to Medicare. “You may not make as much money.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： The inclusion problem at the heart of rehabilitation research

WSS

Stop Congress from blocking public access to science

Prior authorization reform is both possible and imperative

Head of FDA's diagnostics center, who led through Covid, retires

With Roe v Wade overturned, abortion providers work to adapt

TikTok, Instagram influencers need more rules for drug ads

FDA endorses new sterilization method for medical devices

explore

entertainment

Wikipedia

Medicare details structure of new drug price negotiation program

Medicare innovation center doesn’t save money, experts say

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Immunocompromised patients offer clues on chronic Covid

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Cardiologists urge adding sexual orientation, gender identity to health records

How one medical school became remarkably diverse

Maisha Meds is a PBM, but don't call it that

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Health insurers' Q3 question: how much care are people getting?

focus

FDA sets aggressive timeline for overhauling inspection procedures

Nobel honors Karikó and Weissman's enduring partnership

Pumping milk in bathrooms at health conferences is common

What we owe ALS patients — and why one company fell short

Congress extends some pandemic preparedness programs

FDA sets aggressive timeline for overhauling inspection procedures

focus

leisure time

explore

focus